Is Merck Stock A Buy As Moderna Investment Pays Off?

Things are looking up for Merck stock after the Big Pharma bellwether easily topped third-quarter expectations, signed a deal to develop a cancer treatment with Moderna (MRNA) and agreed to a $1.35 billion acquisition of Imago BioSciences (IMGO). In mid-December, Merck (MRK) shares advanced again…#merck #pah #kelunbiotech #mrk #imagobiosciences #acceleronpharma #modernastockabuy #gardasil #imago #seagen
Source: Reuters: Health - Category: Consumer Health News Source Type: news